Search results :

Pimecrolimus

More information: STITCH, PubChem (stereo-specific compounds: 1, 2) and possibly Wikipedia

ATC Code: D11AH02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Headache 7.01% - 25.4% x x x x x x x
Nervous system disorder 7.01% - 25.4% x x x x x x x
Upper respiratory tract infection 4.27% - 19.4% x x x x x
Infestation NOS 4.27% - 19.4% x x x x x x
Infection 4.27% - 19.4% x x x x x x x
Mediastinal disorder 2.44% - 15.8% x x x x x x
Nasopharyngitis 7.35% - 26.5% x x x x x x x
Application site burn 1.49% - 25.9% x x x x x x x x
Cough 2.4% - 15.8% x x x x x x x
Body temperature increased 1.2% - 12.5% x x x x x x x
Influenza 0.7% - 13.2% x x x x x x x
Skin infection common, 2.2% - 6.62% x x x x x x x x
Erythema common x
Gastrointestinal disorder 0.305% - 6.67% x x x x x x x
Immune system disorder 1.33% - 5.15% x x x x x x x x
Vomiting 0.6% - 8% x x x x x x x
Hypersensitivity postmarketing — 1.3% - 5.15% x x x x x x x x
Abdominal pain upper 0.3% - 6.7% x x x x x x x
Throat sore 1.22% - 8.1% x x x x x x x
Impetigo 1.87% - 5.33% x x x x x x x x
Application site reaction 0.61% - 14.6% x x x x x x x
Application site irritation 0.368% - 6.4% x x x x x x x
Otitis media 0.6% - 5.33% x x x x x x x
Pruritus postmarketing, common x x
Asthma 0.299% - 3.7% x x x x x x x
Bronchitis 0.375% - 10.7% x x x x x x x
Folliculitis common, 0.7% - 20% x x x x x x x x
Eye disorder 0.735% - 4% x x x x x x x
Other conjunctivitis 0.299% - 4% x x x x x x x
Herpes simplex 0% - 4% x x x x x x x x
Ear infection 0.6% - 5.7% x x x x x x x
Gastroenteritis 0% - 7.4% x x x x x x x
Nausea 0.375% - 6.7% x x x x x x x
Rhinitis 0% - 6.7% x x x x x x x
Nasal congestion 0.305% - 2.62% x x x x x x x
Bacterial infection 0% - 2.21% x x x x x x x
Asthma aggravated 0% - 3.9% x x x x x x x
Sinusitis 0.6% - 11% x x x x x x x
Breast disorder 0% - 1.49% x x x x x x x
Diarrhoea 0.299% - 7.72% x x x x x x x
Dysmenorrhoea 0% - 1.5% x x x x x x x
Application site pruritus 0% - 5.5% x x x x x x
Pneumonia 0% - 1.5% x x x x x x x
Pharyngitis 0.7% - 8.1% x x x x x x x
Staphylococcal infection 0% - 3.7% x x x x x x x
Varicella 0% - 4% x x x x x x x
Ear and labyrinth disorders 0% - 2.94% x x x x x x x
Abdominal pain 0.299% - 4.41% x x x x x x x
Rhinorrhoea 0% - 1.9% x x x x x x x
Viral infection 0% - 6.62% x x x x x x x
Ear pain 0% - 2.94% x x x x x x x
Sinus congestion 0.299% - 1.12% x x x x x x x
Influenza like illness 0% - 2.7% x x x x x x x
Pharyngitis streptococcal 0% - 3% x x x x x x x
Toothache 0.299% - 2.6% x x x x x x x
Laceration 0% - 1.5% x x x x x x x
Acne 0% - 1.83% x x x x x x x
Wheezing 0% - 1.2% x x x x x x x
Loose stools 0% - 1.2% x x x x x x x
Back pain 0% - 1.83% x x x x x x x
Skin papilloma 0% - 3.31% x x x x x x x x
Bone disorder 0% - 1.83% x x x x x x x
Constipation 0% - 3.7% x x x x x x x
Urticaria postmarketing — 0% - 1.12% x x x x x x x x
Molluscum contagiosum 0% - 1.84% x x x x x x x x
Viral upper respiratory tract infection 0% - 1.5% x x x x x x
Epistaxis 0% - 3.31% x x x x x x x
Arthralgia 0% - 1.52% x x x x x x x
Herpes simplex dermatitis 0% - 1.5% x x x x x x x x
Application site erythema 0% - 2.21% x x x x x x x
Dyspnoea 0% - 1.84% x x x x x x x
Eye infection 0% - 1.1% x x x x x x x
Anaphylactic shock postmarketing x x x x x
Angioedema postmarketing, rare x x x x x
Neoplasm malignant postmarketing x x
Basal cell carcinoma postmarketing x x x x
Squamous cell carcinoma postmarketing x x x x
Dermatitis exfoliative postmarketing x
Rash postmarketing, rare x x
Flushing postmarketing x x x x x
Lymphoma postmarketing x x x x x
Malignant melanoma postmarketing x x x x
Neoplasm skin postmarketing x
Swelling postmarketing x x
Alcohol intolerance postmarketing, rare x x
Skin discolouration postmarketing, rare x x x x
Skin hyperpigmentation postmarketing, rare x x
Leukoderma postmarketing, rare x x
Eye irritation postmarketing x x x
Face oedema postmarketing x x x
Skin cancer x
Oedema x
Malignant histiocytosis x
Leukaemia x
Pain x
Paraesthesia x
Superinfection x x x x x x x
Tonsillitis 0% - 6.3% x x x x x x x
Acute bronchitis 0% - 1.5% x x x x x x x
Skin atrophy x
Malnutrition x
Unspecified disorder of skin and subcutaneous tissue x
Condition aggravated x
Skin exfoliation x
Furuncle x
Carcinoma colon x
Eczema herpeticum x
Sensitisation x x x x x x x
Phototoxicity x x x x x x x
Arthritis bacterial x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ELIDEL / Elidel, Topical cream

Side effects:34
Source:Medsafe

PIMECROLIMUS / ELIDEL

Side effects:74
Source:FDA

PIMECROLIMUS / ELIDEL

Side effects:75
Source:FDA

PIMECROLIMUS

Side effects:76
Source:FDA Structured Product Label

PIMECROLIMUS / ELIDEL

Side effects:84
Source:FDA

Pimecrolimus

Side effects:86
Source:FDA Structured Product Label

PIMECROLIMUS / ELIDEL

Side effects:86
Source:FDA

PIMECROLIMUS / ELIDEL

Side effects:92
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label